McKESSON CORPORATION (MCK) Gross Margin
- Gross margin · 12 months: Value 3.64%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 3.64% | Gross profit / revenue. Period ending 2026-06-30. $14.96B ÷ $410.98B × 100 ≈ 3.64% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 14.96B USD | Gross Profit |
| Revenue | 410.98B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 396.03B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $14.96B | $410.98B | $396.03B | 3.64% |
| 2026-03-31 | $14.55B | $403.43B | $388.88B | 3.61% |
| 2025-12-31 | $14.14B | $397.96B | $383.81B | 3.55% |
| 2025-09-30 | $13.74B | $387.09B | $373.35B | 3.55% |
| 2025-06-30 | $13.45B | $377.60B | $364.14B | 3.56% |
| 2025-03-31 | $13.32B | $359.05B | $345.73B | 3.71% |
| 2024-12-31 | $13.27B | $344.58B | $331.31B | 3.85% |
| 2024-09-30 | $13.14B | $330.19B | $317.05B | 3.98% |
| 2024-06-30 | $12.96B | $313.75B | $300.79B | 4.13% |
| 2024-03-31 | $12.83B | $308.95B | $296.12B | 4.15% |
| 2023-12-31 | $12.31B | $301.51B | $289.20B | 4.08% |
| 2023-09-30 | $12.33B | $291.10B | $278.77B | 4.24% |
| 2023-06-30 | $12.36B | $284.04B | $271.68B | 4.35% |
| 2023-03-31 | $12.36B | $276.71B | $264.35B | 4.47% |
| 2022-12-31 | $12.61B | $273.90B | $261.29B | 4.60% |
| 2022-09-30 | $12.86B | $272.03B | $259.16B | 4.73% |
| 2022-06-30 | $13.12B | $268.45B | $255.32B | 4.89% |
| 2022-03-31 | $13.13B | $263.97B | $250.84B | 4.97% |
| 2021-12-31 | $13.11B | $257.01B | $243.90B | 5.10% |
| 2021-09-30 | $12.83B | $250.99B | $238.16B | 5.11% |
| 2021-06-30 | $12.48B | $245.22B | $232.74B | 5.09% |
| 2021-03-31 | $12.15B | $238.23B | $226.08B | 5.10% |
| 2020-12-31 | $12.19B | $237.62B | $225.43B | 5.13% |
| 2020-09-30 | $12.07B | $234.19B | $222.13B | 5.15% |
| 2020-06-30 | $11.94B | $231.00B | $219.07B | 5.17% |
| 2020-03-31 | $12.02B | $231.05B | $219.03B | 5.20% |
| 2019-12-31 | $11.89B | $224.94B | (m) | 5.28% |
| 2019-09-30 | $11.82B | $221.98B | (m) | 5.33% |
| 2019-06-30 | $11.76B | $217.44B | (m) | 5.41% |
| 2019-03-31 | $11.75B | $214.32B | (m) | 5.48% |
| 2018-12-31 | $11.63B | $213.52B | (m) | 5.45% |
| 2018-09-30 | $11.37B | $210.93B | (m) | 5.39% |
| 2018-06-30 | $11.40B | $209.91B | (m) | 5.43% |
| 2018-03-31 | $11.18B | $208.36B | (m) | 5.37% |
| 2017-12-31 | $10.90B | $205.44B | (m) | 5.31% |
| 2017-09-30 | $11.00B | $201.96B | (m) | 5.45% |
| 2017-06-30 | $10.92B | $199.85B | (m) | 5.47% |
| 2017-03-31 | $11.27B | $198.53B | (m) | 5.68% |
| 2016-12-31 | $11.33B | $196.50B | (m) | 5.76% |
| 2016-09-30 | $11.39B | $194.27B | (m) | 5.86% |
| 2016-06-30 | $11.47B | $193.07B | (m) | 5.94% |
| 2016-03-31 | $11.42B | $190.88B | (m) | 5.98% |
| 2015-12-31 | $11.48B | $189.13B | (m) | 6.07% |
| 2015-09-30 | $11.51B | $187.72B | (m) | 6.13% |
| 2015-06-30 | $11.53B | $183.12B | (m) | 6.29% |
| 2015-03-31 | $11.41B | $179.04B | (m) | 6.37% |
| 2014-12-31 | $11.17B | $173.87B | (m) | 6.42% |
| 2014-09-30 | $10.08B | $161.20B | (m) | 6.25% |
| 2014-06-30 | $9.18B | $149.43B | (m) | 6.14% |
| 2014-03-31 | $8.31B | $137.61B | (m) | 6.04% |
| 2013-12-31 | $7.86B | $130.37B | (m) | 6.03% |
| 2013-09-30 | $7.67B | $127.16B | (m) | 6.03% |
| 2013-06-30 | $7.34B | $123.96B | (m) | 5.92% |
| 2013-03-31 | $6.98B | $122.45B | (m) | 5.70% |
| 2012-12-31 | $6.83B | $123.53B | (m) | 5.53% |
| 2012-09-30 | $6.73B | $123.19B | (m) | 5.46% |
| 2012-06-30 | $6.66B | $123.55B | (m) | 5.39% |
| 2012-03-31 | $6.57B | $122.73B | (m) | 5.35% |
| 2011-12-31 | $6.47B | $119.89B | (m) | 5.40% |
| 2011-09-30 | $6.37B | $117.30B | (m) | 5.43% |
| 2011-06-30 | $6.09B | $114.61B | (m) | 5.31% |
| 2011-03-31 | $5.97B | $112.08B | (m) | 5.33% |
| 2010-12-31 | $5.80B | $109.87B | (m) | 5.28% |
| 2010-09-30 | $5.80B | $109.90B | (m) | 5.27% |
| 2010-06-30 | $5.76B | $109.50B | (m) | 5.27% |
| 2010-03-31 | $5.68B | $108.70B | (m) | 5.22% |
| 2009-12-31 | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | $5.38B | $106.63B | (m) | 5.04% |
| 2008-12-31 | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2008-03-31 | $5.01B | $101.70B | (m) | 4.93% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |